Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SEB Capital/Financing Update 2011

Feb 28, 2011

2966_rns_2011-02-28_645f0b20-b434-4e55-950e-3745331eef16.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

Regarding registration of non-equities

Regarding registration of non-equities

Vilnius, Lithuania, 2011-02-28 07:53 CET (GLOBE NEWSWIRE) -- February 28 2011
Central Securities Depository of Lithuania opened general securities accounts
for two SEB Bank issues:

ISIN code LT1000402370

Type of securities Non-equities

Units 6 767

Bond nominal value EUR 100 (LTL 345.28)

Total nominal value EUR 676 700 (LTL 2 336 509.76)

Financial instrument AstraZeneca Plc, Swedbank AB, Skanska AB

Bond start date 23-02-2011

Redemption date 13-03-2013

Maturity 749 days

Currency EUR

Credit risk Issuer's risk, without extra insurance

Listing This issue will not be listed

Bond issue prospectus Published

ISIN code LT1000402388

Type of securities Non-equities

Units 5 257

Bond nominal value EUR 100 (LTL 345.28)

Total nominal value EUR 525 700 (LTL 1 815 136.96)

Financial instrument AstraZeneca Plc, Swedbank AB, Skanska AB

Bond start date 23-02-2011

Redemption date 13-03-2013

Maturity 749 days

Currency EUR

Credit risk Issuer's risk, without extra insurance

Listing This issue will not be listed

Bond issue prospectus Published

     Evaldas Čepulis       Deputy Director
     Trading and Capital Markets
     (8 5) 268 2375